Int J Radiat Biol 2000, 76: 1297–1303 CrossRefPubMed 8 Courdi A,

Int J Radiat Biol 2000, 76: 1297–1303.CrossRefPubMed 8. Courdi A, Brassart N, Herault J, Chauvel P: The depth-dependent radiation response of human melanoma cells exposed to 65 MeV protons. Br J Radiol 1994, 67: 800–804.CrossRefPubMed 9. Chiquet C, Grange JD, Ayzac L, Chauvel P, Patricot LM, Devouassoux-Shisheboran M:

Effects buy Sotrastaurin of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas. Br J Ophthalmol 2000, 84: 98–102.CrossRefPubMed 10. Ristic-Fira AM, Petrovic IM, Koricanac LB, Valastro LM, Privitera G, Cuttone G: Assessment of the inhibitory effects of different radiation qualities or chemotherapeutic agents on a human melanoma cell line. Phys Med 2008, 24: 187–195.CrossRefPubMed 11. Petrovic IM, Koricanac LB, Todorovic DV, Ristic-Fira AM, Valastro LM, Privitera G, Cuttone G: Viability of a human melanoma cell after single and combined treatment with fotemustine, dacarbazine, and proton irradiation. Ann N Y Acad Sci 2007, 1095: 154–164.CrossRefPubMed 12. Koricanac LB, Petrovic I, Privitera

G, Cuttone G, Ristic-Fira A: HTB140 melanoma cells under proton irradiation and/or alkylating agents. Russ J Phys Chem A 2007, 81: 1467–1470.CrossRef 13. Cirrone P, Cuttone G, Lojacono PA, Lo Nigro S, Mongelli V, Patti IV, Privitera G, Raffaele L, Rifuggiato D, Sabini MG, et al.: A 62-MeV proton beam for the treatment of ocular melanoma at Laboratori Nazionali Napabucasin nmr del Sud-INFN. IEEE T Nucl Sci 2004, 51: 860–865.CrossRef 14. Absorbed dose determination in external beam radiotherapy: an international code of practice for dosimetry based on standards of absorbed dose to water IAEA Technical Report Series N 2000, 398: 135–150. 15. Skehan P, Storeng R, Scudiero D, Monks A, McMahon

J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR: New colorimetric why cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990, 82: 1107–1112.CrossRefPubMed 16. Petrovic I, Ristic-Fira A, Todorovic D, Valastro L, Cirrone P, Cuttone G: Radiobiological analysis of human melanoma cells on the 62 MeV CATANA proton beam. Int J Radiat Biol 2006, 82: 251–265.CrossRefPubMed 17. Soengas MS, Lowe SW: Apoptosis and melanoma chemoresistance. Oncogene 2003, 22: 3138–3151.CrossRefPubMed 18. Houghton AN, Real FX, Davis LJ, Cordon-Cardo C, Old LJ: Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells. J Exp Med 1987, 165: 812–829.CrossRefPubMed 19. Marshall ES, Matthews JH, Shaw JH, Nixon J, Tumewu P, Finlay GJ, Holdaway KM, Baguley BC: Radiosensitivity of new and established human melanoma cell lines: comparison of [3H]thymidine incorporation and soft agar clonogenic assays. Eur J Cancer 1994, 30A: 1370–1376.CrossRefPubMed 20.

Related posts:

  1. This metabolic activity of melanoma
  2. Cancer Genet Cytogenet 2003, 140: 145–152 CrossRefPubMed 10 Cher
  3. BJU Int 2007, 99: 1223–1229 CrossRefPubMed 16 Jones TD, Eble JN,
  4. Infect Immun 2009,77(6):2447–2454 CrossRefPubMed 26 Zarnowski R,
  5. CrossRefPubMed 37 Sabet NS, Subramaniam G, Navaratnam P, Sekaran
This entry was posted in Antibody. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>